Oncology & Cancer

New technology makes tumor eliminate itself

A new technology developed by UZH researchers enables the body to produce therapeutic agents on demand at the exact location where they are needed. The innovation could reduce the side effects of cancer therapy and may hold ...

Medical research

FDA approves immunotherapy for dMMR endometrial cancer

The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after treatment ...

Medical research

Environmental exposures can affect therapeutic drugs

Humans are exposed to various environmental or dietary molecules that can attenuate or even increase the effect of therapeutic drugs. Studies on the industrial chemical bisphenol A and the phytoestrogen genistein, for example, ...

Parkinson's & Movement disorders

Toward a better understanding of Parkinson's disease

A new study, published today in Nature Structural and Molecular Biology, moves researchers closer to understanding one of the crucial proteins involved in Parkinson's disease.

Neuroscience

Dendritic Golgi as key cause of degenerative brain disease

A joint research team of DGIST (Daegu Gyeongbuk Institute of Science and Technology) has identified the early neuropathic mechanism of polyglutamine brain disease, one of the representative degenerative brain diseases. They ...

Cardiology

Limiting protein reduces post-heart attack injury in mice

According to the Centers for Disease Control and Prevention, approximately 735,000 Americans experience a heart attack each year. Opening a blocked coronary artery to restore blood flow to the heart prevents sudden cardiac ...

page 1 from 10